Johnson & Johnson coronavirus vaccine targeted to be launched in early 2021

pharmanewsdaily- March 31, 2020 0

Johnson & Johnson said that it has selected a lead coronavirus vaccine candidate from constructs it has been working on since the start of this ... Read More

Janssen to acquire skin disease drug candidate bermekimab from XBiotech

pharmanewsdaily- December 8, 2019 0

Janssen Biotech acquisition of bermekimab: Janssen Biotech, a Janssen Pharmaceutical Company of Johnson & Johnson, has agreed to acquire all rights to bermekimab, an investigational ... Read More

Janssen bags Stelara FDA approval for ulcerative colitis treatment

pharmanewsdaily- October 22, 2019 0

Stelara FDA approval for ulcerative colitis treatment : The Janssen Pharmaceutical Companies of Johnson & Johnson has bagged approval from the US Food and Drug ... Read More

Janssen bags Xarelto FDA approval to prevent blood clots in acutely ill patients

pharmanewsdaily- October 18, 2019 0

Xarelto FDA approval : The Janssen Pharmaceutical Companies of Johnson & Johnson has secured approval from the US Food and Drug Administration (FDA) for Xarelto ... Read More

Janssen’s Ponesimod OPTIMUM trial in MS meets primary endpoint

pharmanewsdaily- July 29, 2019 0

Ponesimod OPTIMUM trial results :  Johnson & Johnson's Janssen Pharmaceutical said that the phase 3 OPTIMUM clinical trial evaluating ponesimod yielded positive results compared to ... Read More

Guselkumab meets primary endpoints in phase 3 psoriatic arthritis program

pharmanewsdaily- June 15, 2019 0

Johnson & Johnson’s Janssen Pharmaceutical said that its IL-23 p19 inhibitor TREMFYA (guselkumab) met the primary endpoints of American College of Rheumatology 20% improvement (ACR20) ... Read More

Janssen Pharmaceutical’s IMBRUVICA and Rituximab combo wins FDA approval for waldenström’s macroglobulinemia treatment

pharmanewsdaily- August 27, 2018 0

Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has received approval from the US Food and Drug Administration (FDA) for its combination treatment of IMBRUVICA ... Read More